GB2406517B - Minocycline controlled release pharmaceutical composition - Google Patents

Minocycline controlled release pharmaceutical composition

Info

Publication number
GB2406517B
GB2406517B GB0421759A GB0421759A GB2406517B GB 2406517 B GB2406517 B GB 2406517B GB 0421759 A GB0421759 A GB 0421759A GB 0421759 A GB0421759 A GB 0421759A GB 2406517 B GB2406517 B GB 2406517B
Authority
GB
United Kingdom
Prior art keywords
minocycline
pharmaceutical composition
controlled release
release pharmaceutical
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0421759A
Other versions
GB2406517A (en
GB0421759D0 (en
Inventor
Paul Anthony Fleming
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Accord UK Ltd
Original Assignee
Alpharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma Ltd filed Critical Alpharma Ltd
Priority to GB0524368A priority Critical patent/GB2420708A/en
Publication of GB0421759D0 publication Critical patent/GB0421759D0/en
Publication of GB2406517A publication Critical patent/GB2406517A/en
Application granted granted Critical
Publication of GB2406517B publication Critical patent/GB2406517B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0421759A 2003-09-30 2004-09-30 Minocycline controlled release pharmaceutical composition Expired - Fee Related GB2406517B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0524368A GB2420708A (en) 2003-09-30 2004-09-30 Tetracycline controlled release pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0322848A GB0322848D0 (en) 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form

Publications (3)

Publication Number Publication Date
GB0421759D0 GB0421759D0 (en) 2004-11-03
GB2406517A GB2406517A (en) 2005-04-06
GB2406517B true GB2406517B (en) 2006-07-12

Family

ID=29287107

Family Applications (3)

Application Number Title Priority Date Filing Date
GB0322848A Ceased GB0322848D0 (en) 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form
GB0421759A Expired - Fee Related GB2406517B (en) 2003-09-30 2004-09-30 Minocycline controlled release pharmaceutical composition
GB0524368A Withdrawn GB2420708A (en) 2003-09-30 2004-09-30 Tetracycline controlled release pharmaceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB0322848A Ceased GB0322848D0 (en) 2003-09-30 2003-09-30 Tetracycline controlled release pharmaceutical dosage form

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0524368A Withdrawn GB2420708A (en) 2003-09-30 2004-09-30 Tetracycline controlled release pharmaceutical composition

Country Status (1)

Country Link
GB (3) GB0322848D0 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2016162754A1 (en) 2015-04-07 2016-10-13 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1117270A (en) * 1966-06-06 1968-06-19 Ncr Co A process for treating minute polymeric capsules
CA1071935A (en) * 1975-08-18 1980-02-19 Takeda Chemical Industries Ltd. Method of producing microcapsules with coacervated oil-and-fat as the wall material
EP0841062A1 (en) * 1995-07-21 1998-05-13 Daiichi Pharmaceutical Co., Ltd. Granular preparation and process for producing the same
WO2000076481A1 (en) * 1999-06-14 2000-12-21 Cosmo S.P.A. Mesalazine controlled release oral pharmaceutical compositions
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1117270A (en) * 1966-06-06 1968-06-19 Ncr Co A process for treating minute polymeric capsules
CA1071935A (en) * 1975-08-18 1980-02-19 Takeda Chemical Industries Ltd. Method of producing microcapsules with coacervated oil-and-fat as the wall material
EP0841062A1 (en) * 1995-07-21 1998-05-13 Daiichi Pharmaceutical Co., Ltd. Granular preparation and process for producing the same
WO2000076481A1 (en) * 1999-06-14 2000-12-21 Cosmo S.P.A. Mesalazine controlled release oral pharmaceutical compositions
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
GB2406517A (en) 2005-04-06
GB0524368D0 (en) 2006-01-04
GB0322848D0 (en) 2003-10-29
GB2420708A (en) 2006-06-07
GB0421759D0 (en) 2004-11-03

Similar Documents

Publication Publication Date Title
EP1656115A4 (en) Controlled release compositions
GB0302671D0 (en) Pharmaceutical formulations
HK1089697A1 (en) Modafinil modified release pharmaceutical compositions
TWI319318B (en) Modified release pharmaceutical formulation
HU0301154D0 (en) Pharmaceutical composition
EP1607088A4 (en) Controlled release composition
GB0300427D0 (en) Pharmaceutical composition
AU2003260803A8 (en) Sustained release pharmaceutical composition
EP1802346A4 (en) Sustained release pharmaceutical composition
EP1753405A4 (en) Controlled release pharmaceutical formulation
EP1646355A4 (en) Pharmaceutical formulations
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) Pharmaceutical composition
PL376840A1 (en) Prolonged release pharmaceutical composition
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
GB0302672D0 (en) Pharmaceutical formulations
HK1093896A1 (en) Medicinal composition
EP1478353A4 (en) Sustained release pharmaceutical composition
GB0423800D0 (en) New pharmaceutical formulations
GB0300885D0 (en) Pharmaceutical composition
EP1600445A4 (en) Medicinal composition
GB2406517B (en) Minocycline controlled release pharmaceutical composition
GB0306933D0 (en) Pharmaceutical composition
ZA200603030B (en) Modafinil modified release pharmaceutical compositions

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130930